We confirmed the suitability of BCMA to reflect vaccine induced IgA responses by demonstrating that ALS-BCMA ELISA results correlated with ALS-IgA ELISA and flow cytometric plasmablast results obtained in previous oral cholera and ETEC vaccine trials (15–18). This evidence concerns the gene CD79A and vibrio infectious disease.